Product Code: ETC044942 | Publication Date: Jun 2023 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 |
The Japan chemotherapy market size is estimated to be USD 3.7 billion in 2020 and is expected to reach USD 5.6 billion by 2026, expanding at a CAGR of 6.4%. Factors such as the increasing prevalence of cancer, rising demand for novel treatments, technological advancements in drug delivery systems, increasing availability of generic drugs due to patent expirations are driving the growth of this market. However, factors such as high cost associated with chemotherapy treatment may hamper the growth during the forecast period.
Japan has one of the highest percentages of elderly populations and hence a higher burden from various diseases including cancer that will drive demand for advanced therapies like chemotherapy over others throughout the forecast period. The country also has a highly developed healthcare infrastructure which facilitates access to quality medical care by patients suffering from various types of cancers making them eligible candidates for chemotherapeutic treatment options available in Japan . Additionally, technological advancements have led to improved efficacy and safety profiles along with reduced side effects observed after administration leading towards an increased usage rate amongst patients suffering from different forms or stages cancer in recent years..
In addition , government initiatives focusing on early detection methods such as screening programs initiated by Japanese Ministry Of Health Labour And Welfare ( MHLW ) also provide impetus towards chemotherapies since they can help reduce mortality rates significantly through early diagnosis and timely intervention . Moreover , introduction & approval of new targeted anticancer agents such as vandetanib aiming at providing more effective treatments while reducing toxicity levels further bolster use cases within Japan's therapeutic landscape . Thus , all aforementioned factors cumulatively contribute towards sustaining momentum for chemotherapy market during 2020 - 2026 timeline thereby propelling it's subsequent growth trajectory across japanese region .
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan Chemotherapy Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan Chemotherapy Market Revenues & Volume, 2019 & 2026F |
3.3 Japan Chemotherapy Market - Industry Life Cycle |
3.4 Japan Chemotherapy Market - Porter's Five Forces |
3.5 Japan Chemotherapy Market Revenues & Volume Share, By Drug Class, 2019 & 2026F |
3.6 Japan Chemotherapy Market Revenues & Volume Share, By Indication, 2019 & 2026F |
3.7 Japan Chemotherapy Market Revenues & Volume Share, By Route of Drug Administration, 2019 & 2026F |
3.8 Japan Chemotherapy Market Revenues & Volume Share, By End-Users, 2019 & 2026F |
4 Japan Chemotherapy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Japan Chemotherapy Market Trends |
6 Japan Chemotherapy Market, By Types |
6.1 Japan Chemotherapy Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Japan Chemotherapy Market Revenues & Volume, By Drug Class, 2016 - 2026F |
6.1.3 Japan Chemotherapy Market Revenues & Volume, By Alkylating Agents, 2016 - 2026F |
6.1.4 Japan Chemotherapy Market Revenues & Volume, By Mitotic Inhibitors, 2016 - 2026F |
6.1.5 Japan Chemotherapy Market Revenues & Volume, By Antimetabolites, 2016 - 2026F |
6.1.6 Japan Chemotherapy Market Revenues & Volume, By Topoisomerase Inhibitors, 2016 - 2026F |
6.1.7 Japan Chemotherapy Market Revenues & Volume, By Antitumor Antibiotic, 2016 - 2026F |
6.2 Japan Chemotherapy Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Japan Chemotherapy Market Revenues & Volume, By Lung Cancer, 2016 - 2026F |
6.2.3 Japan Chemotherapy Market Revenues & Volume, By Breast Cancer, 2016 - 2026F |
6.2.4 Japan Chemotherapy Market Revenues & Volume, By Colorectal Cancer, 2016 - 2026F |
6.2.5 Japan Chemotherapy Market Revenues & Volume, By Prostate Cancer, 2016 - 2026F |
6.2.6 Japan Chemotherapy Market Revenues & Volume, By Stomach Cancer, 2016 - 2026F |
6.2.7 Japan Chemotherapy Market Revenues & Volume, By Lymphoma, 2016 - 2026F |
6.2.8 Japan Chemotherapy Market Revenues & Volume, By Ovarian Cancer, 2016 - 2026F |
6.2.9 Japan Chemotherapy Market Revenues & Volume, By Ovarian Cancer, 2016 - 2026F |
6.3 Japan Chemotherapy Market, By Route of Drug Administration |
6.3.1 Overview and Analysis |
6.3.2 Japan Chemotherapy Market Revenues & Volume, By Intravenous, 2016 - 2026F |
6.3.3 Japan Chemotherapy Market Revenues & Volume, By Oral, 2016 - 2026F |
6.3.4 Japan Chemotherapy Market Revenues & Volume, By Subcutaneous, 2016 - 2026F |
6.3.5 Japan Chemotherapy Market Revenues & Volume, By Intra-Muscular, 2016 - 2026F |
6.3.6 Japan Chemotherapy Market Revenues & Volume, By Intravesicular, 2016 - 2026F |
6.3.7 Japan Chemotherapy Market Revenues & Volume, By Topical, 2016 - 2026F |
6.3.8 Japan Chemotherapy Market Revenues & Volume, By Intraventricular/Intrathecal, 2016 - 2026F |
6.3.9 Japan Chemotherapy Market Revenues & Volume, By Intraventricular/Intrathecal, 2016 - 2026F |
6.4 Japan Chemotherapy Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 Japan Chemotherapy Market Revenues & Volume, By Specialty Centers, 2016 - 2026F |
6.4.3 Japan Chemotherapy Market Revenues & Volume, By Hospitals & Clinics, 2016 - 2026F |
7 Japan Chemotherapy Market Import-Export Trade Statistics |
7.1 Japan Chemotherapy Market Export to Major Countries |
7.2 Japan Chemotherapy Market Imports from Major Countries |
8 Japan Chemotherapy Market Key Performance Indicators |
9 Japan Chemotherapy Market - Opportunity Assessment |
9.1 Japan Chemotherapy Market Opportunity Assessment, By Drug Class, 2019 & 2026F |
9.2 Japan Chemotherapy Market Opportunity Assessment, By Indication, 2019 & 2026F |
9.3 Japan Chemotherapy Market Opportunity Assessment, By Route of Drug Administration, 2019 & 2026F |
9.4 Japan Chemotherapy Market Opportunity Assessment, By End-Users, 2019 & 2026F |
10 Japan Chemotherapy Market - Competitive Landscape |
10.1 Japan Chemotherapy Market Revenue Share, By Companies, 2019 |
10.2 Japan Chemotherapy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |